Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay-Reference-Cited by-同舟云学术

Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay

Published:2020-09-25 Issue:11 Volume:15 Page:3699-3715
ISSN:1754-2189
Container-title:Nature Protocols
language:en
Short-container-title:Nat Protoc

Author:

Nie Jianhui^ORCID,Li Qianqian,Wu Jiajing,Zhao Chenyan,Hao Huan,Liu Huan,Zhang Li,Nie Lingling,Qin Haiyang,Wang Meng,Lu Qiong,Li Xiaoyu,Sun Qiyu,Liu Junkai,Fan Changfa,Huang Weijin^ORCID,Xu Miao^ORCID,Wang Youchun^ORCID

Funder

Bill and Melinda Gates Foundation

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology

Link

https://www.nature.com/articles/s41596-020-0394-5.pdf

Reference43 articles.

1. Chen, Y. et al. High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients. J. Infect. 81, 420–426 (2020).

2. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536–544 (2020).

3. Chen, Y., Liu, Q. & Guo, D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol. 92, 418–423 (2020).

4. Li, C., Yang, Y. & Ren, L. Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species. Infect. Genet. Evol. 82, 104285 (2020).

5. Wu, A. et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 27, 325–328 (2020).

Cited by 326 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine efficacy, safety, and regulatory controls;mRNA Therapeutics;2025

2. TMPRSS2-specific antisense oligonucleotides inhibit host cell entry of emerging viruses;Virology;2024-12

3. Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamsters;Molecular Therapy - Methods & Clinical Development;2024-09

4. Construction of pseudotyped human coronaviruses and detection of pre-existing antibodies in the human population;Biosafety and Health;2024-09

5. An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection;npj Vaccines;2024-08-31